|
Subgroup
|
n
|
Mean of anti-PT IgG and 95% CI (IU/mL)
|
Pa
|
Number of subjects (%) in concentrations of anti-PT IgG
|
Pc
|
|---|
| | | | |
<30IU/mL
|
≥30IU/mL
|
≥100IU/mL
| |
|---|
|
Total
|
1313
|
14.21(12.29-16.13)
| |
1196(91.09%)
|
93(7.08%)
|
24(1.83%)
| |
|
Home location
|
|
City
|
660
|
14.51(11.43-17.58)
|
0.76
|
609(92.27%)
|
51(7.73%)
|
13(1.97%)
|
0.18
|
|
County
|
653
|
13.92(11.62-16.23)
| |
587(89.89%)
|
66(10.11%)
|
11(1.68%)
| |
|
Gender
| | | | | | | |
|
Male
|
654
|
15.09(12.43-17.73)
|
0.37
|
589(90.06%)
|
65(9.94%)
|
15(2.29%)
|
0.14
|
|
Female
|
659
|
13.35(10.57-16.12)
| |
607(92.11%)
|
52(7.89%)
|
9(1.36%)
| |
|
Age (average age)
|
|
0-2(1.94)
|
80
|
10.91(7.01-14.82)
|
0.55
|
72(90%)
|
8(10.0%)
|
1(1.25%)
|
0.44
|
|
3-4(4.2)
|
79
|
9.95(5.74-14.17)
| |
75(94.94%)
|
4(5.06%)
|
1(1.26%)
| |
|
5-6(5.8)
|
79
|
10.80(4.95-16.65)
| |
75(94.94%)
|
4(5.06%)
|
1(1.26%)
| |
|
7-12(9.4)
|
61
|
9.45(6.04-12.86)
|
0.03b
|
57(93.44%)
|
4(6.56%)
|
0(0)
| |
|
13-19(17.4)
|
175
|
18.44(11.08-25.81)
| |
155(88.57%)
|
20(11.43%)
|
6(3.43%)
| |
|
20-30(23.8)
|
256
|
15.70(9.89-21.5)
| |
237(92.58%)
|
19(7.42%)
|
6(2.34%)
| |
|
31-40(35.7)
|
204
|
13.60(9.85-17.34)
| |
188(92.16%)
|
16(7.84%)
|
3(1.47%)
| |
|
41-50(46.0)
|
173
|
15.42(9.34-21.51)
| |
153(88.44%)
|
20(11.56%)
|
3(1.73%)
| |
|
> 51(64.5)
|
206
|
14.02(10.94-17.10)
| |
184(89.32%)
|
22(10.68%)
|
3(1.46%)
| |
-
a Based on two sample t-test and one-Way ANOVA.
-
b Two sample t-test between 1–2 years and 13–19 years group.
-
c Based on nonparametric tests for 2 independent sample and Kruskal-wallis H.
